Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yangqing Ma
Observed name:
Ma Yangqing
Institutions:
Shanghai University of Traditional Chinese Medicine,
Shuguang Hospital
Observed institutions:
Shanghai University of Traditional Chinese Medicine,
Shuguang Hospital
ORCID:
0009-0006-8871-341X
Observed ORCID:
0009-0006-8871-341X
OpenAlex ID:
A5101318917
Lower NKG2D expression in hepatic natural killer cells predicts poorer prognosis for chronic hepatitis B patients with cirrhosis
2024
·
Yangqing Ma
, Dabing Ping
, et al.
·
Human Immunology
·
4
Serum Golgi Protein 73 as a Predictor of Virologic Response to Entecavir Antiviral Therapy in Patients with Chronic Hepatitis B and Liver Fibrosis: A Retrospective Study
2025
·
Yangqing Ma
, Zhimin Zhao
, et al.
·
Clinical Therapeutics
·
1
The Efficacy of Preventing Portal Hypertension and Treating Cirrhosis Decompensation Due to Hepatitis B with Fuzheng Huayu Tablets, Entecavir and Carvedilol: study protocol for a multicenter randomized controlled trial
2023
·
Yanan Guo
, Zhengxin Li
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
3
Citation count:
5
H-index:
1
I10-index:
Year
Topic
Type